The professional's guide to product selection
Benadryl Allergy contains acrivastine which provides provides symptomatic relief in conditions believed to depend wholly or partly upon the triggered release of histamine. It is a potent competitive histamine H1 antagonist which lacks significant anti-cholinergic effects, and has a low potential to penetrate the central nervous system. It is a non sedating antihistamine.
Contains provitamin B5, which gently helps sensitive skin to repair its natural protective barrier while keeping it soft, smooth and moisturised. The water-in-oil formulation seals in the skin’s natural moisture and provides optimal conditions to allow gentle skin recovery without drying out baby’s delicate skin, keeping it healthy and hydrated. Apply at every nappy change
Betacap Scalp Application complies with the specification given in the monograph for betamethasone valerate scalp application BP. Betacap Scalp Application includes a coconut-oil related emollient ingredient to reduce the drying effect that a standard alcoholic vehicle may otherwise have on the scalp. The vehicle also contains isopropyl alcohol, which has antiseptic activity
Betamethasone valerate is potent corticosteroid with topical anti-inflammatory activity and pruritic manifestations of steroid responsive dermatoses
Betamethasone valerate is potent corticosteroid with topical anti-inflammatory activity and pruritic manifestations of steroid responsive
Betamethasone is a corticosteroid with topical anti-inflammatory activity. Betamethasone valerate ready diluted (Betnovate RD) preparations are indicated for maintenance treatment once an acute episode has been treated effectively with a continuous course of betamethasone valerate (Betnovate).
Bettamousse contains betamethasone, a glucocorticosteroid that has topical anti-inflammatory activity. Bettamousse is used for the treatment of steroid-responsive dermatoses of the scalp, such as psoriasis. Topical application by massaging into the affected areas. Contains betamethasone valerate, a glucocorticosteroid which has topical anti-inflammatory activity.
Bimekizumab is a humanised IgG1/κ monoclonal antibody that selectively binds with high affinity to IL-17A, IL-17F and IL-17AF cytokines, blocking their interaction with the IL-17RA/IL-17RC receptor complex. Elevated concentrations of IL-17A and IL-17F have been implicated in the pathogenesis of several immune-mediated inflammatory diseases including plaque psoriasis. Bimekizumab inhibits these proinflammatory cytokines, resulting in the normalization of skin inflammation and as a consequence improvement in clinical symptoms associated with psoriasis. From in vitro models, bimekizumab was shown to inhibit psoriasis-related gene expression and cytokine production to a greater extent than inhibition of IL-17A alone.
Boots Derma Care Itch Relief cream contains crotamiton for effective relief of itching and works for 10 hours
Brodalumab is a recombinant fully human monoclonal immunoglobulin IgG2 antibody that binds with high affinity to human IL-17RA and blocks the biological activities of the pro-inflammatory cytokines IL-17A, IL-17F, IL-17A/F heterodimer and IL-25, resulting in inhibition of the inflammation and clinical symptoms associated with psoriasis. IL-17RA is a protein expressed on the cell surface and is a required component of receptor complexes used by multiple IL-17 family cytokines. IL-17 family cytokine concentrations have been reported to be increased in psoriasis. Blocking IL-17RA inhibits IL-17 cytokine-induced responses resulting in normalisation of inflammation in the skin.